Novel Cardiac Imaging Risk Score for Mortality Prediction in Duchenne Muscular Dystrophy
- 2 November 2022
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 45 (6) , 1221-1231
Abstract
Cardiovascular disease is the leading cause of death in patients with Duchenne Muscular Dystrophy (DMD), but there is significant cardiomyopathy phenotypic variability. Some patients demonstrate rapidly progressive disease and die at a young age while others survive into the fourth decade. Criteria to identify DMD subjects at greatest risk for early mortality could allow for increased monitoring and more intensive therapy. A risk score was created describing the onset and progression of left ventricular dysfunction and late gadolinium enhancement in subjects with DMD. DMD subjects prospectively enrolled in ongoing observational studies (which included cardiac magnetic resonance [CMR]) were used to validate the risk score. A total of 69 subjects had calculable scores. During the study period, 12 (17%) died from complications of DMD. The median risk score was 3 (IQR [2,5]; range [0,9]). The overall risk score applied at the most recent imaging age was associated with mortality at a median age of 17 years (IQR [16,20]) (HR 2.028, p < 0.001). There were no deaths in subjects with a score of less than two. Scores were stable over time. An imaging-based risk score allows risk stratification of subjects with DMD. This can be quickly calculated during a clinic visit to identify subjects at greatest risk of early death.Keywords
Funding Information
- Ackerman/Nicholoff Family
- National Heart, Lung, and Blood Institute (K23HL123938)
- U.S. Food and Drug Administration (R01FD006649)
- Fighting Duchenne Foundation
- Fight DMD/Jonah & Emory Discovery Grant
This publication has 24 references indexed in Scilit:
- Myocardial Fibrosis Burden Predicts Left Ventricular Ejection Fraction and Is Associated With Age and Steroid Treatment Duration in Duchenne Muscular DystrophyJournal of the American Heart Association, 2015
- Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patientsJournal of Cardiovascular Magnetic Resonance, 2014
- Predictive Value of Myocardial Delayed Enhancement in Duchenne Muscular DystrophyPediatric Cardiology, 2014
- All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular DystrophyJACC, 2013
- Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic functionJournal of Cardiovascular Magnetic Resonance, 2013
- Duchenne Muscular Dystrophy: Continuous Noninvasive Ventilatory Support Prolongs SurvivalRespiratory Care, 2011
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?The International Journal of Cardiovascular Imaging, 2008
- Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Muscular DystrophyJACC, 2007
- Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular DystrophyCirculation, 2005